Citigroup (C) and Evercore ISI are acting as book-running managers for the proposed IPO and as representatives of the underwriters. RBC Capital Markets and William Blair are acting as joint ...

We recently compiled a list of the 15 Best New Tech Stocks To Invest In. In this article, we are going to take a look at ...

In 2024, global and US markets saw a slight increase in IPOs. Syntax Data used its FIS classification system to analyze the ...

After what many considered a “slow” year for IPOs, January has ushered in a string of biotechs filing to go public. But 2024 ...

When top executives at Boston cybersecurity startup Snyk sat down last year to talk about hiring more software engineers, the ...

This edition of the Bermuda Public Companies Update summarises significant transactions involving Bermuda companies listed on the New York ...

Vishal Rao replaces Bryan Palma as Trellix CEO and will also continue to serve as chief executive of Skyhigh Security, the ...

Insulin delivery device maker Beta Bionics said on Wednesday it was targeting a valuation of as much as $615.9 million in its initial public offering in the United States, underscoring a gradual ...

Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases ...

Of the total EMA Partners IPO offer, 50% is reserved for qualified institutional buyers, 35% for retail investors, and 15% ...

Meta Platforms has gained over 1,200% since 2012. The company is now investing heavily in artificial intelligence, bolstering ...